Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
BMO Capital analyst Keith Bachman maintains Infosys (NYSE:INFY) with a Market Perform and lowers the price target from $21 t...
Susquehanna analyst James Friedman maintains Infosys (NYSE:INFY) with a Negative and lowers the price target from $15 to $14.
HSBC analyst Yogesh Aggarwal downgrades Infosys (NYSE:INFY) from Buy to Hold and announces $20.1 price target.
Infosys (INFY) exceeded revenue expectations, with flat Y/Y growth and increased EPS. TCV of significant deals was $4.5B. FY25 ...
Acquisition demonstrates Infosys' commitment to the automotive ecosystem and strengthens its footprint across Europe
Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.
For the Financial Year 2024, the Board recommended a final dividend of `20 per share (0.24 per ADS) and additionally a special ...
